AZELASTINE HYDROCHLORIDE

AZELASTINE HYDROCHLORIDE was reported 7077 times

AZELASTINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PH BODY FLUID INCREASED 6 0.2609
1 GASTROINTESTINAL SUBMUCOSAL TUMOUR 6 0.1304
2 TRANSFERRIN INCREASED 7 0.1250
3 CARDIAC VALVE SCLEROSIS 6 0.0833
4 PRODUCT DELIVERY MECHANISM ISSUE 317 0.0589
5 PROLONGED EXPIRATION 13 0.0496
6 COSTOVERTEBRAL ANGLE TENDERNESS 6 0.0366
7 HYDROCHOLECYSTIS 6 0.0324
8 INFUSION SITE DISCHARGE 47 0.0268
9 INFUSION SITE THROMBOSIS 7 0.0261
10 PERITONEAL ADHESIONS 6 0.0236
11 PRECANCEROUS CONDITION 14 0.0209
12 OXYGEN SATURATION INCREASED 7 0.0206
13 SPUTUM PURULENT 13 0.0198
14 INFUSION SITE BRUISING 38 0.0176
15 INFUSION SITE MASS 18 0.0166
16 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 7 0.0164
17 PATIENT DISSATISFACTION WITH DEVICE 4 0.0159
18 CEREBRAL ARTERIOSCLEROSIS 6 0.0155
19 INFUSION SITE HAEMORRHAGE 47 0.0143
20 INFUSION SITE SCAR 6 0.0135
21 DEATH OF RELATIVE 5 0.0123
22 PO2 INCREASED 6 0.0118
23 PRODUCT LEAKAGE 64 0.0114
24 REFLUX LARYNGITIS 5 0.0113
25 BLADDER HYPERTROPHY 5 0.0113
26 LEFT ATRIAL ENLARGEMENT 6 0.0111
27 PERIORBITAL PAIN 9 0.0106
28 INFUSION SITE DISCOMFORT 11 0.0106
29 DEVICE INFUSION ISSUE 25 0.0101
30 INFUSION SITE SWELLING 63 0.0100
31 MULTIPLE ALLERGIES 78 0.0099
32 SCAR PAIN 4 0.0099
33 INFUSION SITE PRURITUS 30 0.0095
34 TREATMENT FAILURE 782 0.0094
35 INFUSION SITE NODULE 9 0.0094
36 ALLERGIC SINUSITIS 8 0.0093
37 INFUSION SITE URTICARIA 6 0.0090
38 INFUSION SITE ERYTHEMA 74 0.0088
39 ALLERGY TO PLANTS 4 0.0088
40 SEASONAL ALLERGY 122 0.0086
41 PRODUCT AFTER TASTE 8 0.0084
42 INFUSION SITE WARMTH 10 0.0082
43 DEVICE LOOSENING 7 0.0081
44 INFUSION SITE RASH 11 0.0080
45 INFUSION SITE DISCOLOURATION 7 0.0080
46 CHORIORETINOPATHY 11 0.0077
47 NASAL CRUSTING 5 0.0077
48 INFUSION SITE VESICLES 4 0.0076
49 SINUSITIS BACTERIAL 8 0.0076
50 INFUSION SITE PAIN 97 0.0075
51 PRODUCT CONTAINER SEAL ISSUE 13 0.0075
52 INFUSION SITE IRRITATION 9 0.0070
53 DEVICE MAINTENANCE ISSUE 4 0.0068
54 INFUSION SITE INDURATION 10 0.0067
55 CHRONIC SINUSITIS 25 0.0067
56 ALLERGIC COUGH 5 0.0065
57 ABULIA 6 0.0065
58 PCO2 DECREASED 6 0.0062
59 BLOOD IMMUNOGLOBULIN A DECREASED 4 0.0061
60 HEAT ILLNESS 4 0.0059
61 EYELID PAIN 12 0.0059
62 PNEUMONIA INFLUENZAL 7 0.0059
63 HELICOBACTER GASTRITIS 7 0.0056
64 FACIAL DISCOMFORT 4 0.0056
65 PRODUCT DESIGN ISSUE 4 0.0056
66 NASAL PRURITUS 7 0.0056
67 SINUS OPERATION 12 0.0050
68 ANTEROGRADE AMNESIA 3 0.0050
69 MAST CELL ACTIVATION SYNDROME 7 0.0050
70 POST-ACUTE COVID-19 SYNDROME 6 0.0048
71 RHINALGIA 13 0.0047
72 ENDOCRINE OPHTHALMOPATHY 4 0.0046
73 SUPERFICIAL INJURY OF EYE 5 0.0046
74 NASAL DISCOMFORT 36 0.0045
75 OBSTRUCTION 18 0.0045
76 PLEUROTHOTONUS 4 0.0044
77 GASTROINTESTINAL BACTERIAL INFECTION 5 0.0044
78 UPPER-AIRWAY COUGH SYNDROME 36 0.0044
79 ADMINISTRATION SITE PAIN 5 0.0043
80 INSURANCE ISSUE 66 0.0043
81 SPINAL CORD DISORDER 7 0.0043
82 INCORRECT DRUG ADMINISTRATION RATE 18 0.0042
83 OXYGEN CONSUMPTION INCREASED 10 0.0042
84 PROSTATE INFECTION 4 0.0042
85 SINUS DISORDER 81 0.0041
86 PRODUCT ODOUR ABNORMAL 42 0.0040
87 ADHESION 6 0.0040
88 HORDEOLUM 17 0.0039
89 OXYGEN SATURATION ABNORMAL 11 0.0039
90 INFUSION SITE INFECTION 9 0.0039
91 BONE DEMINERALISATION 4 0.0038
92 HYPERTENSIVE HEART DISEASE 7 0.0037
93 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
94 MIDDLE EAR EFFUSION 8 0.0036
95 DERMATITIS CONTACT 40 0.0035
96 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
97 PARANASAL SINUS HYPERSECRETION 13 0.0034
98 DEVICE DEFECTIVE 58 0.0033
99 HYPOSMIA 5 0.0033
100 SINUS HEADACHE 19 0.0032
101 PARANASAL SINUS DISCOMFORT 12 0.0032
102 EAR INFECTION 84 0.0032
103 SUBCUTANEOUS HAEMATOMA 4 0.0031
104 SINUSITIS 315 0.0031
105 SPUTUM DISCOLOURED 29 0.0031
106 SHOULDER FRACTURE 5 0.0031
107 INFUSION SITE EXTRAVASATION 19 0.0030
108 NASAL POLYPS 15 0.0030
109 PRODUCT DISTRIBUTION ISSUE 28 0.0030
110 INFUSION SITE REACTION 9 0.0030
111 LIP EXFOLIATION 4 0.0030
112 RESPIRATORY TRACT INFECTION 76 0.0029
113 IMMUNOGLOBULINS DECREASED 4 0.0029
114 ACUTE SINUSITIS 5 0.0029
115 CYSTIC FIBROSIS 16 0.0029
116 VERTIGO POSITIONAL 5 0.0029
117 EAR SWELLING 6 0.0028
118 BLOOD IMMUNOGLOBULIN G DECREASED 7 0.0028
119 ALLERGY TO ANIMAL 3 0.0028
120 NOROVIRUS INFECTION 4 0.0028
121 DEVICE ALARM ISSUE 5 0.0028
122 FOOD ALLERGY 21 0.0027
123 CONJUNCTIVITIS ALLERGIC 4 0.0027
124 PRODUCT CONTAINER ISSUE 23 0.0027
125 ATYPICAL PNEUMONIA 8 0.0027
126 UPPER RESPIRATORY TRACT INFECTION 122 0.0026
127 PNEUMONIA PSEUDOMONAL 4 0.0026
128 SINUS CONGESTION 35 0.0026
129 PHARYNGITIS STREPTOCOCCAL 28 0.0026
130 SNEEZING 58 0.0026
131 SINUS PAIN 6 0.0026
132 DISTURBANCE IN SOCIAL BEHAVIOUR 6 0.0025
133 FOREIGN BODY SENSATION IN EYES 16 0.0025
134 HYPERPHAGIA 10 0.0025
135 RESPIRATORY TRACT CONGESTION 39 0.0025
136 GASTROINTESTINAL INFECTION 22 0.0025
137 PRODUCT TASTE ABNORMAL 33 0.0024
138 DEVICE MALFUNCTION 170 0.0024
139 DYSPNOEA AT REST 7 0.0024
140 RESPIRATORY SYNCYTIAL VIRUS INFECTION 21 0.0024
141 VEIN RUPTURE 4 0.0024
142 PRODUCTIVE COUGH 114 0.0024
143 DEVICE CONNECTION ISSUE 5 0.0024
144 SLEEP DEFICIT 5 0.0024
145 PHYSICAL DECONDITIONING 6 0.0023
146 THERAPEUTIC PRODUCT INEFFECTIVE 9 0.0023
147 HIATUS HERNIA 30 0.0023
148 TREATMENT DELAYED 4 0.0023
149 PRODUCT PACKAGING DIFFICULT TO OPEN 6 0.0023
150 PRODUCT DOSE OMISSION ISSUE 672 0.0023
151 DIASTOLIC DYSFUNCTION 7 0.0023
152 ACROCHORDON 3 0.0023
153 ANIMAL BITE 6 0.0022
154 RHINITIS ALLERGIC 10 0.0022
155 DEVICE BREAKAGE 91 0.0022
156 STUPOR 7 0.0022
157 BODY TEMPERATURE ABNORMAL 4 0.0022
158 ARTHROPOD BITE 16 0.0022
159 NASAL CONGESTION 125 0.0021
160 EYE PAIN 120 0.0021
161 EYE INFECTION 24 0.0021
162 ASTHMA 240 0.0021
163 SUSPECTED COVID-19 7 0.0021
164 NARCOLEPSY 4 0.0021
165 SNORING 8 0.0021
166 SKIN ABRASION 10 0.0021
167 GASTRIC INFECTION 8 0.0021
168 HYPERTONIC BLADDER 6 0.0021
169 PATIENT DISSATISFACTION WITH TREATMENT 4 0.0021
170 NO ADVERSE EVENT 374 0.0021
171 GASTROENTERITIS VIRAL 37 0.0020
172 NASAL SEPTUM DEVIATION 4 0.0020
173 HYPOGEUSIA 4 0.0020
174 REGURGITATION 7 0.0020
175 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 34 0.0020
176 EAR PRURITUS 7 0.0020
177 BLEPHARITIS 8 0.0020
178 PAROSMIA 15 0.0020
179 VASODILATATION 5 0.0020
180 VASCULAR DEVICE INFECTION 9 0.0020
181 ENURESIS 8 0.0020
182 SKIN WEEPING 7 0.0020
183 DUODENITIS 6 0.0020
184 PERIORBITAL SWELLING 11 0.0019
185 THROAT IRRITATION 85 0.0019
186 EMPHYSEMA 19 0.0019
187 OROPHARYNGEAL DISCOMFORT 17 0.0019
188 CATHETER SITE ERYTHEMA 4 0.0019
189 THROAT CLEARING 7 0.0019
190 APHONIA 26 0.0019
191 INJECTION SITE DISCHARGE 10 0.0019
192 PRODUCT USE COMPLAINT 29 0.0018
193 SKIN LACERATION 20 0.0018
194 ARTHROPOD STING 3 0.0018
195 RHINOVIRUS INFECTION 7 0.0018
196 SKIN INFECTION 20 0.0018
197 DRUG TOLERANCE DECREASED 5 0.0018
198 HEREDITARY ANGIOEDEMA 19 0.0018
199 BRONCHITIS 130 0.0018
200 DIZZINESS POSTURAL 17 0.0018
201 SWELLING OF EYELID 11 0.0018
202 EAR DISORDER 8 0.0017
203 ORAL PRURITUS 4 0.0017
204 RHINITIS 14 0.0017
205 FUNGAL SKIN INFECTION 7 0.0017
206 EYE DISCHARGE 18 0.0017
207 BRAIN FOG 27 0.0017
208 ROSACEA 8 0.0017
209 VIRAL INFECTION 57 0.0017
210 FOOD POISONING 9 0.0017
211 ERYTHEMA OF EYELID 9 0.0017
212 EXPOSURE VIA SKIN CONTACT 43 0.0017
213 RHINORRHOEA 107 0.0017
214 BLOOD IMMUNOGLOBULIN E INCREASED 4 0.0017
215 EAR PAIN 32 0.0016
216 POOR VENOUS ACCESS 17 0.0016
217 BREATH ODOUR 4 0.0016
218 BRONCHITIS CHRONIC 4 0.0016
219 MASTICATION DISORDER 5 0.0016
220 TENSION HEADACHE 7 0.0016
221 MENISCUS INJURY 10 0.0016
222 WEIGHT FLUCTUATION 17 0.0016
223 FOOT OPERATION 8 0.0016
224 ILLNESS 166 0.0016
225 BLADDER SPASM 3 0.0016
226 CANDIDA INFECTION 27 0.0016
227 SECRETION DISCHARGE 20 0.0016
228 RESPIRATION ABNORMAL 11 0.0016
229 DYSPNOEA EXERTIONAL 60 0.0016
230 DECREASED ACTIVITY 17 0.0016
231 ABDOMINAL INFECTION 4 0.0016
232 ADRENAL DISORDER 3 0.0016
233 COVID-19 274 0.0016
234 DRUG TITRATION ERROR 4 0.0015
235 LIPOMA 4 0.0015
236 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
237 ORAL CANDIDIASIS 20 0.0015
238 IDIOPATHIC PULMONARY FIBROSIS 6 0.0015
239 OCULAR DISCOMFORT 17 0.0015
240 MIDDLE INSOMNIA 28 0.0015
241 PLANTAR FASCIITIS 5 0.0015
242 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
243 INJECTION SITE VESICLES 9 0.0015
244 KIDNEY INFECTION 29 0.0015
245 PULMONARY MASS 22 0.0015
246 ABDOMINAL RIGIDITY 4 0.0015
247 TRIGGER FINGER 6 0.0015
248 DRY EYE 73 0.0015
249 OXYGEN SATURATION DECREASED 81 0.0014
250 TOOTH INFECTION 19 0.0014
251 EOSINOPHIL COUNT INCREASED 12 0.0014
252 COVID-19 PNEUMONIA 17 0.0014
253 NASAL DRYNESS 9 0.0014
254 PHOTOPHOBIA 27 0.0014
255 ELECTRIC SHOCK SENSATION 4 0.0014
256 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
257 LIGAMENT SPRAIN 14 0.0014
258 INCREASED TENDENCY TO BRUISE 13 0.0014
259 PRODUCT DOSE OMISSION IN ERROR 40 0.0014
260 GASTROINTESTINAL SOUNDS ABNORMAL 7 0.0014
261 AORTIC VALVE INCOMPETENCE 6 0.0014
262 PRODUCT DISPENSING ISSUE 6 0.0014
263 COUGH 392 0.0014
264 SKIN SWELLING 12 0.0014
265 CHAPPED LIPS 6 0.0014
266 SPONDYLITIS 5 0.0014
267 FAECES SOFT 10 0.0014
268 PULMONARY FUNCTION TEST DECREASED 6 0.0014
269 DEVICE POWER SOURCE ISSUE 4 0.0014
270 INITIAL INSOMNIA 14 0.0014
271 EAR DISCOMFORT 14 0.0014
272 HYPERACUSIS 5 0.0013
273 BACTERIAL INFECTION 25 0.0013
274 EYE PRURITUS 45 0.0013
275 MENINGITIS ASEPTIC 6 0.0013
276 POSTOPERATIVE WOUND INFECTION 9 0.0013
277 PHARYNGEAL SWELLING 13 0.0013
278 IMPAIRED QUALITY OF LIFE 19 0.0013
279 CRANIOCEREBRAL INJURY 4 0.0013
280 HAEMOGLOBIN INCREASED 6 0.0013
281 LUMBAR VERTEBRAL FRACTURE 6 0.0013
282 BODY HEIGHT DECREASED 14 0.0013
283 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
284 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
285 WHEEZING 77 0.0013
286 OROPHARYNGEAL PAIN 120 0.0013
287 GASTRITIS EROSIVE 6 0.0013
288 ORAL INFECTION 5 0.0013
289 EYE IRRITATION 73 0.0013
290 FEAR OF INJECTION 9 0.0013
291 GESTATIONAL DIABETES 6 0.0013
292 STREPTOCOCCAL INFECTION 7 0.0013
293 LACRIMATION INCREASED 38 0.0013
294 PNEUMONIA VIRAL 4 0.0013
295 DEVICE LEAKAGE 54 0.0012
296 ANOSMIA 18 0.0012
297 INJECTION SITE INFECTION 4 0.0012
298 LIMB INJURY 33 0.0012
299 LISTLESS 4 0.0012
300 CYST 15 0.0012
301 ECZEMA 63 0.0012
302 PNEUMONIA BACTERIAL 11 0.0012
303 CEREBRAL HAEMATOMA 4 0.0012
304 ORAL HERPES 23 0.0012
305 ARTERIOSCLEROSIS 11 0.0012
306 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 20 0.0012
307 PSEUDOMONAS INFECTION 10 0.0012
308 MUSCULOSKELETAL DISCOMFORT 20 0.0012
309 PRODUCT PACKAGING ISSUE 11 0.0012
310 BURSITIS 14 0.0012
311 EPISTAXIS 86 0.0011
312 DEVICE ISSUE 103 0.0011
313 CONJUNCTIVITIS 21 0.0011
314 PHARYNGITIS 14 0.0011
315 SKIN FISSURES 22 0.0011
316 PRE-EXISTING CONDITION IMPROVED 7 0.0011
317 GINGIVITIS 6 0.0011
318 FOOT FRACTURE 21 0.0011
319 IMPAIRED GASTRIC EMPTYING 15 0.0011
320 OCULAR HYPERAEMIA 52 0.0011
321 BLOOD IRON DECREASED 13 0.0011
322 ASTHENOPIA 6 0.0011
323 DEAFNESS UNILATERAL 6 0.0011
324 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 196 0.0011
325 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
326 TASTE DISORDER 22 0.0011
327 NERVE COMPRESSION 10 0.0011
328 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
329 FUNGAL INFECTION 36 0.0011
330 ARTHRITIS INFECTIVE 5 0.0011
331 HEAD DISCOMFORT 19 0.0011
332 TENDERNESS 11 0.0011
333 SLEEP APNOEA SYNDROME 20 0.0010
334 INJECTION SITE DISCOMFORT 11 0.0010
335 INFECTION 150 0.0010
336 RESPIRATORY DISORDER 31 0.0010
337 FAECES HARD 4 0.0010
338 DYSPHONIA 60 0.0010
339 INFLUENZA 114 0.0010
340 MIGRAINE 97 0.0010
341 BREATH SOUNDS ABNORMAL 5 0.0010
342 DYSGEUSIA 75 0.0010
343 FACIAL PAIN 9 0.0010
344 INTERVERTEBRAL DISC PROTRUSION 22 0.0010
345 BLOOD PRESSURE ABNORMAL 20 0.0010
346 GINGIVAL PAIN 8 0.0010
347 CYSTITIS 32 0.0010
348 SALIVARY HYPERSECRETION 10 0.0010
349 TRIGEMINAL NEURALGIA 4 0.0010
350 EYE SWELLING 37 0.0010
351 THERMAL BURN 7 0.0010
352 POST PROCEDURAL INFECTION 8 0.0010
353 CHEST DISCOMFORT 100 0.0010
354 SPINAL STENOSIS 4 0.0010
355 BLOOD POTASSIUM DECREASED 29 0.0010
356 THYROID FUNCTION TEST ABNORMAL 4 0.0010
357 INJECTION SITE DISCOLOURATION 12 0.0010
358 BLOOD SODIUM DECREASED 18 0.0010
359 SPINAL DISORDER 9 0.0009
360 NASOPHARYNGITIS 175 0.0009
361 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
362 SKIN HAEMORRHAGE 14 0.0009
363 TONGUE DISCOMFORT 4 0.0009
364 SCIATICA 15 0.0009
365 ABSCESS LIMB 4 0.0009
366 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 45 0.0009
367 SHOULDER OPERATION 4 0.0009
368 THERAPEUTIC RESPONSE SHORTENED 31 0.0009
369 URINARY TRACT INFECTION 158 0.0009
370 BEHAVIOUR DISORDER 5 0.0009
371 HERPES SIMPLEX 6 0.0009
372 DEVICE PHYSICAL PROPERTY ISSUE 7 0.0009
373 JAW DISORDER 5 0.0009
374 THYROID DISORDER 14 0.0009
375 CHOKING SENSATION 5 0.0009
376 INABILITY TO AFFORD MEDICATION 9 0.0009
377 GINGIVAL SWELLING 4 0.0009
378 CATHETERISATION CARDIAC 4 0.0009
379 WHEELCHAIR USER 4 0.0009
380 ANXIETY DISORDER 3 0.0009
381 GOUT 16 0.0009
382 THROAT TIGHTNESS 24 0.0009
383 DRY THROAT 9 0.0009
384 CONTUSION 85 0.0009
385 SLUGGISHNESS 9 0.0009
386 DEVICE DELIVERY SYSTEM ISSUE 24 0.0009
387 INFUSION RELATED REACTION 58 0.0009
388 LOCALISED INFECTION 21 0.0009
389 RENAL FUNCTION TEST ABNORMAL 4 0.0009
390 DEVICE FAILURE 13 0.0009
391 INCONTINENCE 9 0.0009
392 SKIN TIGHTNESS 4 0.0008
393 INJECTION SITE SWELLING 65 0.0008
394 RETCHING 18 0.0008
395 SARCOIDOSIS 4 0.0008
396 AGEUSIA 21 0.0008
397 CHOLECYSTITIS 10 0.0008
398 SARS-COV-2 TEST POSITIVE 11 0.0008
399 HYPERSENSITIVITY 153 0.0008
400 TENSION 5 0.0008
401 AUTOIMMUNE DISORDER 8 0.0008
402 PRODUCT USE IN UNAPPROVED INDICATION 202 0.0008
403 SENSITIVE SKIN 6 0.0008
404 BLOOD MAGNESIUM DECREASED 7 0.0008
405 HYPERVOLAEMIA 4 0.0008
406 SCOLIOSIS 5 0.0008
407 INTENTIONAL DOSE OMISSION 23 0.0008
408 DEVICE USE ISSUE 14 0.0008
409 BACK DISORDER 13 0.0008
410 FLUID INTAKE REDUCED 4 0.0008
411 VEIN DISORDER 4 0.0008
412 EATING DISORDER 17 0.0008
413 SPINAL OSTEOARTHRITIS 7 0.0008
414 DERMATITIS ATOPIC 42 0.0008
415 BLEPHAROSPASM 5 0.0008
416 AUTOIMMUNE THYROIDITIS 3 0.0008
417 EYE DISORDER 26 0.0008
418 CORONARY ARTERIAL STENT INSERTION 4 0.0008
419 DRY MOUTH 64 0.0008
420 STAPHYLOCOCCAL INFECTION 26 0.0008
421 NECK PAIN 44 0.0008
422 PHOTOSENSITIVITY REACTION 13 0.0008
423 ACCIDENTAL EXPOSURE TO PRODUCT 81 0.0008
424 TOOTH ABSCESS 8 0.0008
425 PRODUCT PREPARATION ERROR 16 0.0008
426 ROTATOR CUFF SYNDROME 10 0.0008
427 CONCUSSION 6 0.0008
428 VARICOSE VEIN 4 0.0008
429 CARDIAC FLUTTER 5 0.0008
430 TOOTHACHE 14 0.0008
431 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 5 0.0008
432 PLATELET COUNT INCREASED 10 0.0008
433 PNEUMOTHORAX 12 0.0008
434 CORONAVIRUS INFECTION 5 0.0008
435 OEDEMA 41 0.0008
436 NEEDLE ISSUE 22 0.0008
437 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
438 CHROMATURIA 17 0.0008
439 SLEEP DISORDER 53 0.0008
440 WRIST FRACTURE 9 0.0008
441 IRRITABLE BOWEL SYNDROME 16 0.0007
442 POOR QUALITY SLEEP 16 0.0007
443 MYASTHENIA GRAVIS 6 0.0007
444 BRONCHIECTASIS 5 0.0007
445 MUSCLE TIGHTNESS 12 0.0007
446 DYSPNOEA 418 0.0007
447 ABDOMINAL DISTENSION 77 0.0007
448 PRODUCT LABEL ISSUE 5 0.0007
449 PNEUMONIA 238 0.0007
450 SPINAL OPERATION 9 0.0007
451 HYPOAESTHESIA ORAL 11 0.0007
452 GENERALISED OEDEMA 9 0.0007
453 HEART RATE ABNORMAL 4 0.0007
454 EXTRASYSTOLES 5 0.0007
455 RESTLESS LEGS SYNDROME 13 0.0007
456 KNEE ARTHROPLASTY 15 0.0007
457 SENSATION OF FOREIGN BODY 6 0.0007
458 DRY SKIN 95 0.0007
459 MUSCULOSKELETAL CHEST PAIN 11 0.0007
460 HYPOXIA 25 0.0007
461 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 37 0.0007
462 HEART RATE INCREASED 70 0.0007
463 HAND FRACTURE 5 0.0007
464 VITAMIN D DECREASED 6 0.0007
465 SCAR 12 0.0007
466 BRONCHOSPASM 10 0.0007
467 BLOOD PRESSURE INCREASED 107 0.0007
468 SPINAL FRACTURE 14 0.0007
469 HEPATIC STEATOSIS 13 0.0007
470 POOR QUALITY DEVICE USED 7 0.0007
471 HYPERSOMNIA 20 0.0007
472 EXERCISE TOLERANCE DECREASED 4 0.0007
473 PARAESTHESIA ORAL 10 0.0007
474 VISION BLURRED 95 0.0007
475 INJECTION SITE RASH 21 0.0007
476 HEADACHE 426 0.0007
477 DECREASED INTEREST 4 0.0007
478 PSYCHIATRIC SYMPTOM 5 0.0007
479 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
480 CATARACT OPERATION 4 0.0007
481 CHILLS 79 0.0007
482 LUNG DISORDER 33 0.0007
483 PULMONARY HYPERTENSION 14 0.0007
484 MALIGNANT MELANOMA 9 0.0007
485 CARDIAC PACEMAKER INSERTION 4 0.0007
486 PETECHIAE 7 0.0007
487 PAIN IN JAW 19 0.0007
488 FULL BLOOD COUNT ABNORMAL 7 0.0007
489 GAIT INABILITY 22 0.0007
490 NEURALGIA 16 0.0007
491 JOINT INJURY 14 0.0007
492 BOWEL MOVEMENT IRREGULARITY 5 0.0007
493 UPPER LIMB FRACTURE 13 0.0007
494 PIGMENTATION DISORDER 4 0.0006
495 GASTROOESOPHAGEAL REFLUX DISEASE 52 0.0006
496 PERIPHERAL SWELLING 99 0.0006
497 ORTHOSTATIC HYPOTENSION 11 0.0006
498 FEELING JITTERY 12 0.0006
499 FLUID RETENTION 32 0.0006
500 BACK PAIN 146 0.0006
501 OBESITY 10 0.0006
502 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
503 HERPES ZOSTER 36 0.0006
504 INJECTION SITE PAIN 191 0.0006
505 FALL 207 0.0006
506 HAEMOGLOBIN ABNORMAL 4 0.0006
507 HYPERCHOLESTEROLAEMIA 6 0.0006
508 FATIGUE 483 0.0006
509 COMPLICATION ASSOCIATED WITH DEVICE 9 0.0006
510 SKIN LESION 17 0.0006
511 PRODUCT USE ISSUE 116 0.0006
512 APATHY 9 0.0006
513 PARKINSONISM 6 0.0006
514 DECUBITUS ULCER 5 0.0006
515 POLYP 4 0.0006
516 NEPHROLITHIASIS 28 0.0006
517 VITREOUS FLOATERS 6 0.0006
518 PRODUCT PREPARATION ISSUE 4 0.0006
519 HOSPICE CARE 6 0.0006
520 DYSGRAPHIA 4 0.0006
521 WALKING AID USER 4 0.0006
522 SKIN DISORDER 20 0.0006
523 ROAD TRAFFIC ACCIDENT 25 0.0006
524 INJECTION SITE PRURITUS 40 0.0006
525 FULL BLOOD COUNT DECREASED 12 0.0006
526 PRODUCT PHYSICAL ISSUE 12 0.0006
527 GLYCOSYLATED HAEMOGLOBIN INCREASED 15 0.0006
528 PRODUCT ADMINISTRATION ERROR 12 0.0006
529 FEEDING DISORDER 12 0.0006
530 ULCER HAEMORRHAGE 4 0.0006
531 INJECTION SITE BRUISING 47 0.0006
532 CATARACT 35 0.0006
533 ABNORMAL LOSS OF WEIGHT 4 0.0006
534 FACIAL PARALYSIS 5 0.0006
535 GINGIVAL BLEEDING 8 0.0006
536 DEVICE RELATED INFECTION 9 0.0006
537 PRURITUS 224 0.0006
538 SKIN EXFOLIATION 49 0.0006
539 BONE PAIN 34 0.0006
540 LYMPHOEDEMA 4 0.0006
541 BASAL CELL CARCINOMA 9 0.0006
542 PROCEDURAL PAIN 16 0.0006
543 FIBROMYALGIA 14 0.0006
544 DEAFNESS 15 0.0006
545 RASH MACULAR 20 0.0006
546 INJECTION SITE URTICARIA 14 0.0006
547 GASTROINTESTINAL DISORDER 51 0.0006
548 HEAD INJURY 18 0.0006
549 DEVICE OCCLUSION 8 0.0006
550 DIZZINESS 282 0.0006
551 CHOKING 11 0.0006
552 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
553 SURGERY 33 0.0006
554 PERICARDIAL EFFUSION 13 0.0006
555 THIRST 10 0.0006
556 RED BLOOD CELL COUNT DECREASED 16 0.0006
557 ARTHRITIS 44 0.0006
558 DERMATITIS ALLERGIC 7 0.0006
559 THERAPY NON-RESPONDER 25 0.0006
560 CELLULITIS 28 0.0006
561 ARTHRALGIA 231 0.0006
562 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
563 LOWER RESPIRATORY TRACT INFECTION 25 0.0005
564 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
565 EXOSTOSIS 5 0.0005
566 FLATULENCE 31 0.0005
567 THERAPY INTERRUPTED 39 0.0005
568 INJECTION SITE NODULE 6 0.0005
569 RASH ERYTHEMATOUS 26 0.0005
570 DENTAL CARIES 6 0.0005
571 FEELING DRUNK 4 0.0005
572 WEIGHT DECREASED 150 0.0005
573 NERVOUSNESS 28 0.0005
574 APPENDICITIS 5 0.0005
575 SWELLING 50 0.0005
576 HYPOTHYROIDISM 17 0.0005
577 INJECTION SITE ERYTHEMA 66 0.0005
578 PULMONARY CONGESTION 7 0.0005
579 REBOUND EFFECT 6 0.0005
580 MUSCLE SPASMS 97 0.0005
581 PRODUCT AVAILABILITY ISSUE 12 0.0005
582 SCAB 6 0.0005
583 DERMATITIS 11 0.0005
584 SWELLING FACE 34 0.0005
585 PULMONARY FIBROSIS 10 0.0005
586 OSTEOARTHRITIS 22 0.0005
587 HERNIA 10 0.0005
588 ANKLE FRACTURE 8 0.0005
589 TENDONITIS 8 0.0005
590 SOMNOLENCE 104 0.0005
591 DEVICE INFORMATION OUTPUT ISSUE 4 0.0005
592 PELVIC FRACTURE 4 0.0005
593 WEIGHT INCREASED 115 0.0005
594 VITAMIN D DEFICIENCY 5 0.0005
595 ABDOMINAL DISCOMFORT 86 0.0005
596 SWOLLEN TONGUE 16 0.0005
597 BLOOD PRESSURE DECREASED 34 0.0005
598 PAIN 314 0.0005
599 FEELING ABNORMAL 122 0.0005
600 PROSTATIC SPECIFIC ANTIGEN INCREASED 7 0.0005
601 DRUG SCREEN POSITIVE 4 0.0005
602 BACTERAEMIA 6 0.0005
603 HAEMATOCRIT DECREASED 10 0.0005
604 HUNGER 7 0.0005
605 HYPERLIPIDAEMIA 6 0.0005
606 POLYNEUROPATHY 6 0.0005
607 MASS 7 0.0005
608 BLOOD PRESSURE FLUCTUATION 12 0.0005
609 BLOOD DISORDER 4 0.0005
610 NIGHT SWEATS 16 0.0005
611 CONSTIPATION 107 0.0005
612 GAIT DISTURBANCE 93 0.0005
613 BALANCE DISORDER 42 0.0005
614 HEART RATE DECREASED 17 0.0005
615 CONDITION AGGRAVATED 147 0.0005
616 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
617 LYMPHADENOPATHY 17 0.0005
618 RASH PRURITIC 26 0.0005
619 POLLAKIURIA 20 0.0005
620 INTENTIONAL PRODUCT USE ISSUE 42 0.0005
621 HEPATIC CIRRHOSIS 9 0.0005
622 PALPITATIONS 56 0.0005
623 URTICARIA 80 0.0005
624 VERTIGO 29 0.0005
625 PAIN IN EXTREMITY 140 0.0005
626 MUSCLE ATROPHY 6 0.0005
627 INSOMNIA 125 0.0005
628 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
629 DIVERTICULITIS 13 0.0005
630 EXTRA DOSE ADMINISTERED 19 0.0005
631 MYDRIASIS 6 0.0005
632 DRUG INEFFECTIVE 615 0.0005
633 HIP FRACTURE 15 0.0005
634 HAEMOPTYSIS 13 0.0005
635 CARDIAC OPERATION 4 0.0005
636 HOT FLUSH 35 0.0005
637 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 33 0.0005
638 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
639 FLUSHING 47 0.0005
640 OSTEOPOROSIS 19 0.0005
641 ABDOMINAL PAIN UPPER 95 0.0005
642 RASH 201 0.0005
643 SPEECH DISORDER 24 0.0005
644 DEHYDRATION 61 0.0005
645 BURNING SENSATION 32 0.0005
646 ANKYLOSING SPONDYLITIS 6 0.0005
647 PHARYNGEAL OEDEMA 7 0.0005
648 APPETITE DISORDER 3 0.0005
649 PURPURA 4 0.0005
650 LETHARGY 26 0.0005
651 ATRIAL FIBRILLATION 44 0.0005
652 PRODUCT SUBSTITUTION ISSUE 26 0.0005
653 NERVE INJURY 5 0.0004
654 THERAPY PARTIAL RESPONDER 7 0.0004
655 MYALGIA 76 0.0004
656 ORAL PAIN 10 0.0004
657 HAEMARTHROSIS 4 0.0004
658 LIP DRY 4 0.0004
659 PNEUMONIA ASPIRATION 11 0.0004
660 MALAISE 193 0.0004
661 ULCER 7 0.0004
662 INTERNAL HAEMORRHAGE 5 0.0004
663 RIB FRACTURE 9 0.0004
664 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0004
665 DIARRHOEA 282 0.0004
666 ASTHENIA 163 0.0004
667 ORAL DISCOMFORT 6 0.0004
668 MEMORY IMPAIRMENT 59 0.0004
669 NEPHROPATHY 4 0.0004
670 NAUSEA 339 0.0004
671 HYPOAESTHESIA 64 0.0004
672 INFLAMMATION 22 0.0004
673 INFLUENZA LIKE ILLNESS 35 0.0004
674 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
675 THROMBOSIS 34 0.0004
676 LIMB DISCOMFORT 13 0.0004
677 VISUAL IMPAIRMENT 52 0.0004
678 RECALLED PRODUCT ADMINISTERED 4 0.0004
679 HYPOACUSIS 18 0.0004
680 POST PROCEDURAL COMPLICATION 8 0.0004
681 LOWER LIMB FRACTURE 8 0.0004
682 ANAPHYLACTIC REACTION 23 0.0004
683 DEPRESSED MOOD 22 0.0004
684 GLAUCOMA 8 0.0004
685 TINNITUS 19 0.0004
686 ERUCTATION 8 0.0004
687 PRESYNCOPE 10 0.0004
688 DYSSTASIA 12 0.0004
689 DISTURBANCE IN ATTENTION 22 0.0004
690 COELIAC DISEASE 4 0.0004
691 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
692 THERAPY CHANGE 4 0.0004
693 BODY TEMPERATURE DECREASED 4 0.0004
694 CARDIAC DISORDER 38 0.0004
695 URINARY INCONTINENCE 12 0.0004
696 BLADDER DISORDER 4 0.0004
697 TOOTH EXTRACTION 5 0.0004
698 HYPERTENSION 85 0.0004
699 DECREASED APPETITE 93 0.0004
700 DYSPHAGIA 38 0.0004
701 ERYTHEMA 82 0.0004
702 PYREXIA 138 0.0004
703 HYPOTENSION 80 0.0004
704 DEPRESSION 90 0.0004
705 DRUG ERUPTION 7 0.0004
706 DYSKINESIA 16 0.0004
707 LIP SWELLING 13 0.0004
708 ERECTILE DYSFUNCTION 10 0.0004
709 TEMPERATURE INTOLERANCE 4 0.0004
710 LEUKOCYTOSIS 7 0.0004
711 OSTEOMYELITIS 7 0.0004
712 INJECTION SITE INDURATION 5 0.0004
713 CHEST PAIN 71 0.0004
714 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
715 THERAPEUTIC RESPONSE DECREASED 23 0.0004
716 SCRATCH 4 0.0004
717 JOINT DISLOCATION 4 0.0004
718 OEDEMA PERIPHERAL 46 0.0004
719 DISCOMFORT 23 0.0004
720 ANXIETY 107 0.0004
721 QUALITY OF LIFE DECREASED 5 0.0004
722 FREQUENT BOWEL MOVEMENTS 10 0.0004
723 SKIN DISCOLOURATION 17 0.0004
724 BLOOD POTASSIUM INCREASED 6 0.0004
725 FAECES DISCOLOURED 8 0.0004
726 PRODUCT PRESCRIBING ISSUE 8 0.0004
727 PULMONARY THROMBOSIS 4 0.0004
728 AKATHISIA 5 0.0004
729 INCREASED APPETITE 7 0.0004
730 OESOPHAGITIS 4 0.0004
731 BLOOD GLUCOSE FLUCTUATION 4 0.0004
732 RENAL DISORDER 17 0.0004
733 BLOOD CHOLESTEROL INCREASED 17 0.0004
734 PERIPHERAL COLDNESS 5 0.0004
735 ACUTE RESPIRATORY FAILURE 7 0.0004
736 GASTROINTESTINAL PAIN 4 0.0004
737 TOOTH FRACTURE 4 0.0004
738 RESPIRATORY DISTRESS 10 0.0004
739 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
740 FEELING COLD 10 0.0004
741 CARPAL TUNNEL SYNDROME 5 0.0004
742 BLOOD TEST ABNORMAL 5 0.0004
743 BLOOD CALCIUM DECREASED 4 0.0004
744 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 72 0.0004
745 HEART RATE IRREGULAR 8 0.0004
746 BLOOD GLUCOSE DECREASED 17 0.0004
747 DISABILITY 7 0.0004
748 DYSURIA 13 0.0004
749 CHOLECYSTECTOMY 4 0.0003
750 TACHYCARDIA 31 0.0003
751 NEOPLASM 4 0.0003
752 GASTRIC HAEMORRHAGE 4 0.0003
753 NEUROPATHY PERIPHERAL 33 0.0003
754 VOMITING 162 0.0003
755 BODY TEMPERATURE INCREASED 7 0.0003
756 JOINT STIFFNESS 9 0.0003
757 INCORRECT DOSE ADMINISTERED 78 0.0003
758 SPLENOMEGALY 4 0.0003
759 INJECTION SITE WARMTH 7 0.0003
760 GALLBLADDER DISORDER 6 0.0003
761 CHOLELITHIASIS 11 0.0003
762 IMMUNODEFICIENCY 5 0.0003
763 ACCIDENT 4 0.0003
764 FEAR 9 0.0003
765 HYPERHIDROSIS 43 0.0003
766 ANAL INCONTINENCE 3 0.0003
767 JOINT SWELLING 40 0.0003
768 APHASIA 10 0.0003
769 MUSCULOSKELETAL STIFFNESS 29 0.0003
770 PNEUMONITIS 9 0.0003
771 NOCTURIA 4 0.0003
772 TYPE 2 DIABETES MELLITUS 11 0.0003
773 LIVER FUNCTION TEST INCREASED 7 0.0003
774 ABNORMAL DREAMS 9 0.0003
775 SKIN CANCER 7 0.0003
776 BLOOD GLUCOSE ABNORMAL 6 0.0003
777 INJECTION SITE MASS 12 0.0003
778 PRODUCT QUALITY ISSUE 44 0.0003
779 LYMPHOMA 5 0.0003
780 MENTAL DISORDER 14 0.0003
781 DRUG INTOLERANCE 31 0.0003
782 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
783 BLISTER 18 0.0003
784 TREMOR 53 0.0003
785 CYANOSIS 5 0.0003
786 PARAESTHESIA 50 0.0003
787 MUSCULAR WEAKNESS 36 0.0003
788 BLOOD URINE PRESENT 6 0.0003
789 IRRITABILITY 19 0.0003
790 GASTRIC ULCER 6 0.0003
791 MUSCULOSKELETAL DISORDER 6 0.0003
792 DIABETES MELLITUS 24 0.0003
793 TOOTH DISORDER 7 0.0003
794 HALLUCINATION, AUDITORY 5 0.0003
795 INJECTION SITE IRRITATION 4 0.0003
796 INTRAOCULAR PRESSURE INCREASED 4 0.0003
797 GLOSSODYNIA 7 0.0003
798 CHOLESTASIS 6 0.0003
799 SENSORY DISTURBANCE 5 0.0003
800 LIVER FUNCTION TEST ABNORMAL 9 0.0003
801 DIPLOPIA 8 0.0003
802 ARTHROPATHY 17 0.0003
803 SEDATION 8 0.0003
804 DYSPEPSIA 30 0.0003
805 MULTIPLE FRACTURES 5 0.0003
806 BEDRIDDEN 4 0.0003
807 GASTRITIS 8 0.0003
808 ACCIDENTAL OVERDOSE 11 0.0003
809 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 14 0.0003
810 RHEUMATOID ARTHRITIS 34 0.0003
811 DEVICE DISLOCATION 13 0.0003
812 DISEASE RECURRENCE 14 0.0003
813 MULTIPLE SCLEROSIS 14 0.0003
814 THERAPY CESSATION 15 0.0003
815 INTESTINAL OBSTRUCTION 11 0.0003
816 PULMONARY OEDEMA 13 0.0003
817 MENTAL STATUS CHANGES 8 0.0003
818 WOUND 8 0.0003
819 SEIZURE 33 0.0003
820 COLD SWEAT 5 0.0003
821 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
822 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
823 FEELING HOT 17 0.0003
824 BACK INJURY 3 0.0003
825 HYPOKINESIA 4 0.0003
826 PRODUCT DISPENSING ERROR 6 0.0003
827 CRYING 10 0.0003
828 TREATMENT NONCOMPLIANCE 15 0.0003
829 GASTROENTERITIS 4 0.0003
830 ASPIRATION 3 0.0003
831 LABORATORY TEST ABNORMAL 8 0.0003
832 EXPIRED PRODUCT ADMINISTERED 9 0.0003
833 URINARY RETENTION 9 0.0003
834 THINKING ABNORMAL 5 0.0003
835 MOBILITY DECREASED 19 0.0003
836 ECONOMIC PROBLEM 4 0.0003
837 STOMATITIS 16 0.0003
838 COLITIS 10 0.0003
839 PLEURAL EFFUSION 16 0.0003
840 SKIN IRRITATION 12 0.0003
841 EPILEPSY 8 0.0003
842 INJECTION SITE REACTION 18 0.0003
843 NIGHTMARE 9 0.0003
844 BLOOD BILIRUBIN INCREASED 7 0.0003
845 PALLOR 7 0.0003
846 INTENTIONAL PRODUCT MISUSE 22 0.0003
847 UNEVALUABLE EVENT 19 0.0003
848 SEPSIS 28 0.0003
849 DEMENTIA 7 0.0003
850 LOSS OF CONSCIOUSNESS 32 0.0002
851 MULTIPLE SCLEROSIS RELAPSE 17 0.0002
852 HYPOGLYCAEMIA 12 0.0002
853 HOSPITALISATION 38 0.0002
854 ADRENAL INSUFFICIENCY 3 0.0002
855 ILL-DEFINED DISORDER 15 0.0002
856 RESTLESSNESS 9 0.0002
857 INJURY ASSOCIATED WITH DEVICE 5 0.0002
858 MANIA 4 0.0002
859 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
860 NEOPLASM MALIGNANT 16 0.0002
861 DYSARTHRIA 9 0.0002
862 COGNITIVE DISORDER 11 0.0002
863 HAEMATOMA 6 0.0002
864 SYNCOPE 23 0.0002
865 HAEMORRHAGE 24 0.0002
866 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
867 DISEASE PROGRESSION 27 0.0002
868 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
869 HAEMOGLOBIN DECREASED 23 0.0002
870 CHRONIC KIDNEY DISEASE 17 0.0002
871 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
872 JAUNDICE 6 0.0002
873 PAIN OF SKIN 6 0.0002
874 ANAEMIA 42 0.0002
875 MOOD ALTERED 6 0.0002
876 BONE DISORDER 4 0.0002
877 PANIC ATTACK 8 0.0002
878 END STAGE RENAL DISEASE 4 0.0002
879 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
880 HAEMATOCHEZIA 12 0.0002
881 SHOCK 5 0.0002
882 MUSCLE TWITCHING 5 0.0002
883 HYPOKALAEMIA 10 0.0002
884 PLATELET COUNT DECREASED 23 0.0002
885 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
886 HALLUCINATION 16 0.0002
887 FRACTURE 4 0.0002
888 OFF LABEL USE 185 0.0002
889 BLOOD GLUCOSE INCREASED 39 0.0002
890 ABDOMINAL PAIN 48 0.0002
891 UNDERDOSE 15 0.0002
892 HAEMORRHOIDS 4 0.0002
893 ALOPECIA 40 0.0002
894 DEEP VEIN THROMBOSIS 13 0.0002
895 PREGNANCY 4 0.0002
896 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
897 DRUG ADMINISTRATION ERROR 6 0.0002
898 PRODUCT STORAGE ERROR 17 0.0002
899 SKIN ULCER 5 0.0002
900 TOOTH LOSS 4 0.0002
901 CONFUSIONAL STATE 31 0.0002
902 ANHEDONIA 5 0.0002
903 EMOTIONAL DISTRESS 23 0.0002
904 HALLUCINATION, VISUAL 4 0.0002
905 RENAL FAILURE 25 0.0002
906 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
907 MOOD SWINGS 6 0.0002
908 ABSCESS 3 0.0002
909 INJECTION SITE HAEMORRHAGE 15 0.0002
910 BREAST CANCER FEMALE 5 0.0002
911 AMNESIA 12 0.0002
912 IMPAIRED HEALING 6 0.0002
913 ANGIOEDEMA 8 0.0002
914 LIVER DISORDER 8 0.0002
915 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
916 PANCREATITIS ACUTE 4 0.0002
917 ANGER 6 0.0002
918 AGITATION 13 0.0002
919 EXPOSURE DURING PREGNANCY 11 0.0002
920 DISORIENTATION 7 0.0002
921 APPLICATION SITE PRURITUS 4 0.0002
922 ABORTION SPONTANEOUS 7 0.0002
923 PULMONARY EMBOLISM 16 0.0002
924 ADVERSE DRUG REACTION 15 0.0002
925 DEVICE DIFFICULT TO USE 11 0.0002
926 MENTAL IMPAIRMENT 4 0.0002
927 RECTAL HAEMORRHAGE 7 0.0002
928 CARDIAC FAILURE CONGESTIVE 13 0.0002
929 HEPATIC ENZYME INCREASED 11 0.0002
930 PSORIASIS 21 0.0002
931 CEREBROVASCULAR ACCIDENT 27 0.0002
932 ABDOMINAL PAIN LOWER 4 0.0002
933 COLITIS ULCERATIVE 7 0.0002
934 INJURY 11 0.0002
935 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
936 SUICIDAL IDEATION 14 0.0002
937 APPLICATION SITE ERYTHEMA 4 0.0002
938 ADVERSE EVENT 14 0.0002
939 CARDIAC FAILURE 12 0.0001
940 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
941 BLINDNESS 6 0.0001
942 NEUTROPHIL COUNT DECREASED 6 0.0001
943 ACNE 11 0.0001
944 ACUTE KIDNEY INJURY 22 0.0001
945 PANCYTOPENIA 8 0.0001
946 WITHDRAWAL SYNDROME 6 0.0001
947 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
948 ANGINA PECTORIS 4 0.0001
949 VAGINAL HAEMORRHAGE 6 0.0001
950 DRUG EFFECT INCOMPLETE 5 0.0001
951 RENAL INJURY 4 0.0001
952 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
953 PANCREATITIS 7 0.0001
954 BRADYCARDIA 7 0.0001
955 EMOTIONAL DISORDER 4 0.0001
956 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
957 ARRHYTHMIA 6 0.0001
958 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
959 MOVEMENT DISORDER 4 0.0001
960 LUNG NEOPLASM MALIGNANT 5 0.0001
961 AGGRESSION 6 0.0001
962 HAEMATURIA 4 0.0001
963 DEVICE USE ERROR 4 0.0001
964 NEOPLASM PROGRESSION 4 0.0001
965 PRODUCT ADHESION ISSUE 4 0.0001
966 CEREBRAL HAEMORRHAGE 4 0.0001
967 SKIN BURNING SENSATION 8 0.0001
968 RESPIRATORY FAILURE 8 0.0001
969 BREAST CANCER 10 0.0001
970 BLOOD CREATININE INCREASED 7 0.0001
971 RENAL IMPAIRMENT 9 0.0001
972 HYPONATRAEMIA 6 0.0001
973 DEATH 90 0.0001
974 MYOCARDIAL INFARCTION 18 0.0001
975 ASCITES 3 0.0001
976 ABNORMAL BEHAVIOUR 4 0.0001
977 CARDIAC ARREST 8 0.0001
978 DRUG INTERACTION 14 0.0001
979 DRUG DOSE OMISSION 14 0.0001
980 COMA 4 0.0001
981 INTERSTITIAL LUNG DISEASE 4 0.0001
982 MUSCULOSKELETAL PAIN 4 0.0001
983 MEDICATION ERROR 4 0.0001
984 DRUG DEPENDENCE 10 0.0001
985 PRODUCT DOSE OMISSION 4 0.0001
986 DRUG DOSE OMISSION BY DEVICE 4 0.0001
987 NEUTROPENIA 6 0.0000
988 OVERDOSE 9 0.0000
989 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
990 THROMBOCYTOPENIA 4 0.0000